345 related articles for article (PubMed ID: 30140882)
61. Changes over time in papanicolaou cytology test and HPV test in a large women's academic center laboratory.
Jones TE; Matsko J; Elishaev E; Clark BZ; Carter G; Harinath L; Zhao C
J Am Soc Cytopathol; 2023; 12(4):307-313. PubMed ID: 37142542
[TBL] [Abstract][Full Text] [Related]
62. Overuse of Cervical Cancer Screening Tests Among Women With Average Risk in the United States From 2013 to 2014.
Wright JD; Chen L; Tergas AI; Melamed A; St Clair CM; Hou JY; Khoury-Collado F; Gockley A; Accordino M; Hershman DL
JAMA Netw Open; 2021 Apr; 4(4):e218373. PubMed ID: 33914050
[TBL] [Abstract][Full Text] [Related]
63. The impact of the COVID-19 pandemic on the Ontario Cervical Screening Program, colposcopy and treatment services in Ontario, Canada: a population-based study.
Meggetto O; Jembere N; Gao J; Walker MJ; Rey M; Rabeneck L; Murphy KJ; Kupets R;
BJOG; 2021 Aug; 128(9):1503-1510. PubMed ID: 33982870
[TBL] [Abstract][Full Text] [Related]
64. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.
de Koning HJ; Meza R; Plevritis SK; ten Haaf K; Munshi VN; Jeon J; Erdogan SA; Kong CY; Han SS; van Rosmalen J; Choi SE; Pinsky PF; Berrington de Gonzalez A; Berg CD; Black WC; Tammemägi MC; Hazelton WD; Feuer EJ; McMahon PM
Ann Intern Med; 2014 Mar; 160(5):311-20. PubMed ID: 24379002
[TBL] [Abstract][Full Text] [Related]
65. Previous cervical cytology and high-risk human papillomavirus testing in a cohort of patients with invasive cervical carcinoma in Shandong Province, China.
Zhang L; Xie F; Wang X; Peng D; Bi C; Jiang L; Zhao D; Tian X; Qi D
PLoS One; 2017; 12(6):e0180618. PubMed ID: 28662160
[TBL] [Abstract][Full Text] [Related]
66. The ASCCP Cervical Cancer Screening Task Force Endorsement and Opinion on the American Cancer Society Updated Cervical Cancer Screening Guidelines.
Marcus JZ; Cason P; Downs LS; Einstein MH; Flowers L
J Low Genit Tract Dis; 2021 Jul; 25(3):187-191. PubMed ID: 34138787
[TBL] [Abstract][Full Text] [Related]
67. How confident can we be in the current guidelines for exiting cervical screening?
Gravitt PE; Landy R; Schiffman M
Prev Med; 2018 Sep; 114():188-192. PubMed ID: 29981791
[TBL] [Abstract][Full Text] [Related]
68. Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population.
Simms KT; Keane A; Nguyen DTN; Caruana M; Hall MT; Lui G; Gauvreau C; Demke O; Arbyn M; Basu P; Wentzensen N; Lauby-Secretan B; Ilbawi A; Hutubessy R; Almonte M; De Sanjosé S; Kelly H; Dalal S; Eckert LO; Santesso N; Broutet N; Canfell K
Nat Med; 2023 Dec; 29(12):3050-3058. PubMed ID: 38087115
[TBL] [Abstract][Full Text] [Related]
69. Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance.
Huh WK; Ault KA; Chelmow D; Davey DD; Goulart RA; Garcia FAR; Kinney WK; Massad LS; Mayeaux EJ; Saslow D; Schiffman M; Wentzensen N; Lawson HW; Einstein MH
Obstet Gynecol; 2015 Feb; 125(2):330-337. PubMed ID: 25569009
[TBL] [Abstract][Full Text] [Related]
70. Designing Guidelines for Those Who Do Not Follow Them: The Impact of Adherence Assumptions on Optimal Screening Guidelines.
Pedersen K; Kristiansen IS; Sy S; Kim JJ; Burger EA
Value Health; 2023 Aug; 26(8):1217-1224. PubMed ID: 37116697
[TBL] [Abstract][Full Text] [Related]
71. Cervical cancer detection by DNA methylation analysis in urine.
Snoek BC; Splunter APV; Bleeker MCG; Ruiten MCV; Heideman DAM; Rurup WF; Verlaat W; Schotman H; Gent MV; Trommel NEV; Steenbergen RDM
Sci Rep; 2019 Feb; 9(1):3088. PubMed ID: 30816167
[TBL] [Abstract][Full Text] [Related]
72. Cervical Cancer Screening: Evolution of National Guidelines and Current Recommendations.
Khan MJ
Clin Obstet Gynecol; 2023 Sep; 66(3):470-477. PubMed ID: 37436937
[TBL] [Abstract][Full Text] [Related]
73. Factors Associated With Guideline-concordant and Excessive Cervical Cancer Screening: A Mixed Methods Study.
Perkins RB; Fuzzell L; Lake P; Brownstein NC; Fontenot HB; Michel A; Whitmer A; Vadaparampil ST
Womens Health Issues; 2024; 34(3):257-267. PubMed ID: 38383228
[TBL] [Abstract][Full Text] [Related]
74. An Alternative to Cytology in Triaging Cisgender Men and Transgender Women With HIV for High-Resolution Anoscopy.
Mudrinich SM; Nguyen MLT; Blemur DM; Wang X; Wang YF; Krishnamurti U; Mosunjac M; Flowers LC
J Low Genit Tract Dis; 2024 Jan; 28(1):101-106. PubMed ID: 38117565
[TBL] [Abstract][Full Text] [Related]
75. Attendance at cervical cancer screening and use of diagnostic and therapeutic procedures on the uterine cervix assessed from individual health insurance data (Belgium, 2002-2006).
Arbyn M; Fabri V; Temmerman M; Simoens C
PLoS One; 2014; 9(4):e92615. PubMed ID: 24690620
[TBL] [Abstract][Full Text] [Related]
76. Colposcopy referral and CIN3+ risk of human papillomavirus genotyping strategies in cervical cancer screening.
Kroon KR; Bogaards JA; Heideman DA; Meijer CJ; Berkhof J
Cancer Epidemiol Biomarkers Prev; 2024 Mar; ():. PubMed ID: 38546394
[TBL] [Abstract][Full Text] [Related]
77. Provider beliefs in effectiveness and recommendations for primary HPV testing in 3 health-care systems.
Kruse GR; Lykken JM; Kim EJ; Haas JS; Higashi RT; Atlas SJ; McCarthy AM; Tiro JA; Silver MI; Skinner CS; Kamineni A
JNCI Cancer Spectr; 2023 Jan; 7(1):. PubMed ID: 36469348
[TBL] [Abstract][Full Text] [Related]
78. Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV.
Hall MT; Simms KT; Murray JM; Keane A; Nguyen DTN; Caruana M; Lui G; Kelly H; Eckert LO; Santesso N; de Sanjose S; Swai EE; Rangaraj A; Owiredu MN; Gauvreau C; Demke O; Basu P; Arbyn M; Dalal S; Broutet N; Canfell K
Nat Med; 2023 Dec; 29(12):3059-3066. PubMed ID: 38087116
[TBL] [Abstract][Full Text] [Related]
79. Cervical Cytology and Histology After Solid Organ Transplant: A Longitudinal Cohort Study.
Long ME; Chantigian PDM; Weaver AL
J Low Genit Tract Dis; 2018 Oct; 22(4):362-366. PubMed ID: 29975335
[TBL] [Abstract][Full Text] [Related]
80. Cost-effectiveness of cervical cancer screening with primary HPV testing for unvaccinated women in Sweden.
Fogelberg S; Clements MS; Pedersen K; Sy S; Sparén P; Kim JJ; Burger EA
PLoS One; 2020; 15(9):e0239611. PubMed ID: 32997696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
